Labshake search
Citations for BioLegend :
101 - 150 of 6287 citations for Galectin 1 Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2024Quote: ... Membranes were blocked overnight in Odyssey PBS Blocking Buffer (Li-Cor) and stained for 2 hours at RT with Syn1 (1:1,000; Biolegend) or γH2AX (1:1,000 ...
-
bioRxiv - Immunology 2022Quote: ... table 1) were diluted in blocking solution (F4/80 [Bio-Rad]: 10 µg/ml, Ly6G [abcam]: 1 µg/ml, MHC-II [BioLegend]: 5 µg/ml), CD163 [Invitrogen] ...
-
bioRxiv - Cell Biology 2021Quote: ... Thrombin Receptor Activator Peptide-6 (TRAP-6; 30μM) or Adenosine Diphosphate (ADP; 30μM) along with CD42b-BV421 (1:60, Biolegend), PAC-1 FITC (1:12 ...
-
bioRxiv - Immunology 2022Quote: ... PBMCs were treated with FcX blocking antibodies (BioLegend, #4422302) to reduce non-specific labeling of the cells ...
-
bioRxiv - Immunology 2021Quote: ... using both human and mouse Fc blocking reagents (BioLegend). Cellular suspensions were loaded on a Chromium Single-Cell Instrument (10x Genomics ...
-
bioRxiv - Immunology 2021Quote: ... Human TruStain FcX Fc receptor blocking reagent (BioLegend #422302) was used at a 1:100 dilution in PBS with 2.5 g bovine serum albumin (Sigma Aldrich #A3059 ...
-
Naked Mole-Rat Hematopoietic Stem and Progenitors are Highly Quiescent with an Inherent Myeloid BiasbioRxiv - Cell Biology 2021Quote: ... using both human and mouse Fc blocking reagents (BioLegend). Cellular suspensions were loaded on a Chromium Single-Cell Instrument (10x Genomics ...
-
Naked Mole-Rat Hematopoietic Stem and Progenitors are Highly Quiescent with an Inherent Myeloid BiasbioRxiv - Cell Biology 2021Quote: ... using both human and mouse Fc blocking reagents (BioLegend). Following fluorescent antibody staining samples were sorted for xenograft cells by Thy1.1/CD34 staining and excluding the “mouse” gate as shown in Figure 3G ...
-
bioRxiv - Cell Biology 2021Quote: ... and blocked with Human TruStain FcX blocking antibody (Biolegend). CD45-PE [clone HI30] ...
-
bioRxiv - Bioengineering 2022Quote: ... Mononuclear cells were blocked with Fc blocking solution (BioLegend) and stained with the following antibody panels ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... and cells treated with FcR blocking antibodies (Biolegend, UK). Cell suspensions were then labelled and sorted according the specific protocol as below ...
-
bioRxiv - Immunology 2020Quote: ... and blocking was performed using Human TruStain FcX (BioLegend). CD3+CD4+CD25+CD127lo/- nTregs and CD3+CD4+CD25- Tconvs were isolated on the Astrios (Beckman Coulter ...
-
bioRxiv - Immunology 2021Quote: ... containing Fc blocking antibody against CD16/CD32 (BioLegend Inc) before staining with antibodies ...
-
bioRxiv - Genomics 2021Quote: ... before Fc receptor blocking (Human TruStain FcX, Biolegend #422302) for 10 minutes ...
-
bioRxiv - Immunology 2022Quote: Barcoded cells were stained with Receptor Blocking Solution (BioLegend) at 20 mg/mL for 5 min at RT on a shaker ...
-
bioRxiv - Immunology 2023Quote: ... an anti-TNFR blocking antibody (BioLegend, Cat no. 113104) was added at 1.25 ng/mL 24 hours prior to IFNγ activation.
-
bioRxiv - Genomics 2023Quote: ... Human TruStain FcX Fc receptor blocking reagent (BioLegend #422302) was used at a 1:100 dilution in cell staining buffer (CSB ...
-
bioRxiv - Immunology 2023Quote: ... Cells were then blocked with FcR blocking reagent (Biolegend) on ice for 10 min followed by addition of surface-antibody cocktail in the mixture for another 60 min ...
-
bioRxiv - Bioengineering 2023Quote: ... and human (TruStain FcX, Fc receptor blocking solution, Biolegend) Fc-blocked for 20 min before staining for surface markers for 30 minutes in FACS buffer (2% FBS in PBS 1x ...
-
bioRxiv - Microbiology 2019Quote: ... Human B cells were incubated in human Fc receptor blocking antibody then stained with Zombie Aqua fixable viability dye (1:500 dilution) (BioLegend), according to manufacturer’s protocol ...
-
bioRxiv - Immunology 2020Quote: ... followed by incubation for 1h at RT in a 1:1000 dilution in blocking buffer of primary Ab (purified anti-Filaggrin polyclonal Ab, clone Poly19058, Biolegend). After washing ...
-
bioRxiv - Neuroscience 2022Quote: ... Sections were then incubated overnight at 4°C with primary antibodies diluted in blocking solution: anti-βIII Tubulin (1/500, Biolegend), anti-RSK2 (1/100 ...
-
bioRxiv - Molecular Biology 2023Quote: ... 10 million cells were resuspended in 1 mL of FACS buffer and 50 μL of Human TruStain FcX Fc Receptor Blocking Solution (BioLegend) was added and left to bind the cells on ice for 15 minutes ...
-
bioRxiv - Immunology 2023Quote: ... were resuspended in labeling buffer (1% BSA in PBS) and underwent Fc blocking for 10 minutes on ice using Human TruStain FcX (BioLegend). Next ...
-
bioRxiv - Immunology 2023Quote: All flow cytometry was performed at Fred Hutchison Cancer Center utilizing a 28-color panel focused on T cell phenotyping (Supplementary Table 1) [33] CVC and PBMC were incubated with Fc-blocking reagent (BioLegend) and fixable UV Blue Live/Dead reagent (ThermoFisher ...
-
bioRxiv - Cell Biology 2024Quote: ... 2 mM EDTA in PBS) and incubated with Fc-blocking reagent (1:200, TruStain FcX, anti-mouse CD16/32, BioLegend). After washing ...
-
bioRxiv - Immunology 2021Quote: ... and after Fc receptor blocking with Human TruStain FcX (Biolegend), cells were stained with the following antibodies in FACS buffer (PBS with 2 % fetal calf serum ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 μL of Fc blocking reagent HumanTruStainFc™ (422302, Biolegend) and incubated 5 min at 4°C ...
-
bioRxiv - Cancer Biology 2021Quote: ... and Human TruStain FcX™ Fc Receptor Blocking Solution (BioLegend). The stained samples were then incubated and stained with Alexa Fluor® 700 anti-human CD45 Antibody (BioLegend) ...
-
bioRxiv - Immunology 2019Quote: ... in some experiments an anti-MR1 blocking antibody (26.5, Biolegend) was added to the co-cultures.
-
bioRxiv - Immunology 2019Quote: ... MHC class II blocking antibody (M5/114.15.2, Biolegend, 2.5μg/ml) was added to DC cultures one hour prior to adding the CD4+ T cells ...
-
bioRxiv - Microbiology 2021Quote: ... markers after blocking with anti-mouse CD16/32 antibodies (BioLegend). Cells were then permeabilized and treated with DNase to expose BrdU epitopes followed by anti-BrdU-FITC and 7-AAD (7-amino-actinomycin D ...
-
bioRxiv - Cell Biology 2020Quote: ... cells pre-incubated with human Fc-receptor blocking solution (BioLegend) to reduce nonspecific staining carried out at a concentration of (0.01% ...
-
bioRxiv - Immunology 2021Quote: ... Blocking Solution (5 μL of Human Trustain FcX (BioLegend #422302), and13.7 μL of a 10% Bovine Serum Albumin (BSA) ...
-
bioRxiv - Immunology 2022Quote: ... Blocking Solution (5 μL of Human Trustain FcX (BioLegend #422302), and 13.7 μL of a 10% Bovine Serum Albumin (BSA) ...
-
bioRxiv - Immunology 2022Quote: ... blocked with Human TruStain FcX Fc receptor blocking solution (BioLegend) for 10 minutes ...
-
bioRxiv - Immunology 2023Quote: ... upon blocking cells with anti-CD16/32 (clone: 93, Biolegend). The following antibodies (clone in brackets ...
-
bioRxiv - Microbiology 2023Quote: ... Following blocking with an anti-FcψR antibody (BioLegend, clone 93), cells were stained on ice with CD45 (BD BioSciences ...
-
bioRxiv - Immunology 2023Quote: ... the cells were preincubated with Fc receptor blocking solution (Biolegend) to reduce nonspecific binding and subsequently stained with fluorochrome-conjugated anti-human antibodies against CD45 ...
-
bioRxiv - Neuroscience 2023Quote: ... 10 μL of Fc blocking reagent HumanTruStainFc™ (422302, Biolegend) and incubated 5 min at 4°C ...
-
bioRxiv - Immunology 2022Quote: ... and incubated with 5μl TruStain FcX receptor blocking solution (Biolegend) for 5min at RT ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... antibodies after blocking by anti-CD16/32 antibodies (BioLegend 101302). Dead cells were excluded via 7-aminoactinomycin D staining.
-
bioRxiv - Immunology 2024Quote: ... Human TruStain FcX™ (Fc Receptor Blocking Solution, 422302, BioLegend) was used at 1:100 dilution for blocking nonspecific binding ...
-
bioRxiv - Cancer Biology 2024Quote: ... and after Fc receptor blocking with Human TruStain FcX (Biolegend), cells were stained with the following antibodies in FACS buffer (PBS with 2% fetal calf serum ...
-
bioRxiv - Neuroscience 2023Quote: ... containing 10% blocking agent (Normal Serum Block, CAT# 927502, Biolegend) in 0.1 M PBS with 0.5% Triton X-100 for 2 hours ...
-
bioRxiv - Cancer Biology 2024Quote: ... slides were incubated sequentially with avidin/biotin blocking system (Biolegend), goat anti-rabbit secondary antibody (Biovision) ...
-
bioRxiv - Cancer Biology 2024Quote: ... or anti-mouse CD16/CD32 blocking antibody (101319, Biolegend, USA). Both surface and intracellular antigens were detected using a panel of fluorochrome-conjugated monoclonal antibodies ...
-
bioRxiv - Cell Biology 2020Quote: ... Slides were incubated with the following primary antibodies diluted in blocking buffer overnight at 4°C – chicken anti-keratin 14 (1:800, Biolegend 906001), rabbit anti-SCD1 (1:500 ...
-
bioRxiv - Developmental Biology 2021Quote: ... ENR media was supplemented with 500 ng/ml rAspn and 1 μg/ml of ultra-LEAF™ CD44 function blocking antibody (Clone IM7; Biolegend) or equal amount of isotype control IgG2b kappa (Clone RTK4533 ...
-
bioRxiv - Cancer Biology 2022Quote: The following primary antibodies with indicated dilution in blocking buffer were used: Rabbit anti-Tuj1 (Covance, BioLegend, MRB-435P, 1:1,000), Mouse anti-Tuj1 (Covance ...